Short-Term Effects of Protein Intake, Blood Pressure, and Antihypertensive Therapy on Glomerular Filtration Rate in the Modification of Diet in Renal Disease Study

Journal of the American Society of Nephrology

Volumn 7, Issue 10, 1996, Pages 2097-2109

  Levey, Andrew S ^a,b   Beck, Gerald J ^a   Bosch, Juan P ^a   Caggiula, Arlene W ^a   Greene, Tom ^a   Hunsicker, Lawrence G ^a   Klahr, Saulo ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b TUFTS MEDICAL CENTER   (United States)

Author keywords

Antihypertensive therapy; Blood pressure; Dietary protein; GFR

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; GLOMERULUS FILTRATION; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MEAN ARTERIAL PRESSURE; PRIORITY JOURNAL; PROTEIN INTAKE; PROTEIN RESTRICTION;

EID: 0030377766     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Smith HW. Diseases of the kidney and urinary tract. In: The Kidney: Structure and Function in Health and Disease. New York: Oxford University Press; 1951:836-887.
2. Levey AS: Assessing the effectiveness of therapy to prevent the progression of renal disease. Am J Kidney Dis 1993;22:207-214.
3. Premen AJ: Potential mechanisms mediating postprandial renal hyperemia and hyperfiltration. FASEB (Fed Am Soc Exp Biol) J 1988;2:131-137.
4. Keane WF, Anderson S, Aurell M, de Zeeuw D, Narins RG, Povar G: Angiotensin converting enzyme inhibitors and progressive renal insufficiency: Current experience and future directions. Ann Intern Med 1989;111:503-516.
5. Lewis EJ, Hunsicker LG, Bain RP Rohde RD, for the Collaborative Study Group: The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med 1993;329:1456-1462.
6. Peterson JC, Adler S, Burkart JM, et al.: Blood pressure control, proteinuria, and the progression of renal disease: The Modification of Diet in Renal Disease Study Group: Ann Intern Med 1995;123:754-762.
7. Pedrini MT, Levey AS, Lau J, Chalmers TC, Wang PH: The effect of dietary protein restriction on the progression of diabetic and non-diabetic renal disease: A meta-analysis. Ann Intern Med 1996;124:627-632.
8. Maschio G, Alberti D, Janin G, et al., the Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group: Effect of angiotensin-converting enzyme inhibitor benazepril on the progression of chronic renal insufficiency. N Engl J Med 1996;334:939-945.
9. Klahr S: The Modification of Diet in Renal Disease Study. N Engl J Med 1989;320:864-866.
10. Modification of Diet in Renal Disease Study Group (prepared by Beck GJ, Berg RL, Coggins CH, Gassman JJ, Hunsicker LG, Williams GW): Design and statistical issues of the Modification of Diet in Renal Disease Trial. Controlled Clin Trials 1991;12:566-586.
11. Modification of Diet in Renal Disease Study Group: The Modification of Diet in Renal Disease Study: Design, methods, and results from the Feasibility Study. Am J Kidney Dis 1992;20:18-33.
12. Klahr S, Levey AS, Beck GJ, et al., the Modification of Diet in Renal Disease Study Group: The effects of dietary protein restriction and blood pressure control on the progression of renal disease. N Engl J Med 1994;330: 877-884.
13. Joint National Committee: 1988 Report of the Joint National Committee in Detection, Evaluation and Treatment of High Blood Pressure. Arch Intern Med 1988;148: 1023-1038.
14. Maroni BJ, Steinman TI, Mitch WE: A method for estimating nitrogen intake of patients with chronic renal failure. Kidney Int 1985;27:58-65.
15. Frisancho AR. Instructions for using the frameter, weight fat guide and anthropometric standards. Ann Arbor, MI: Health Products; 1989:29-30.
16. Modification of Diet in Renal Disease Study Group (prepared by Levey AS, Adler S, Caggiula AW, et al.): Effects of dietary protein restriction on the progression of advanced renal disease in the Modification of Diet in Renal Disease Study. Am J Kidney Dis 1996;27:652-663.
17. Modification of Diet in Renal Disease (MDRD) Study Group (presented by Gassman JJ, Berg RL, Byington RP, Hebert LA, Lambdin KE, Tanna A): Selecting a point estimator of blood pressure from consecutive measurements [Abstract]. Controlled Clin Trials 1991;12:709-710.
18. 99mTc-DTPA to inulin. Am J Kidney Dis 1990;16: 224-235.
19. Levey AS, Greene T, Schluchter MD, et al., the MDRD Study Group, the DCCT Research Group: Glomerular filtration rate measurements in clinical trials. J Am Soc Nephrol 1993;4:1159-1171.
20. Kleinbaum DG, Kupper LL, Muller KE. Applied Regression Analysis and Other Multivariable Methods. Boston: PWS-KENT; 1988:102-180.
21. Jennrich RI, Schluchter MD: Unbalanced repeated-measures models with structured covariance matrices. Biometrics 1986;42:805-820.
22. Cressie N. Statistics for Spatial Data. New York: John Wiley & Sons; 1991.
23. Liu K: Measurement error and its impact on partial correlation and multiple linear regression analyses. Am J Epidemiol 1988;127:864-873.
24. Fuller WA. Measurement Error Models. New York: Wiley; 1987:103-124.
25. Pullman TN, Alving AS, Dern RJ, Landowne M: The influence of dietary protein intake on the specific renal function in normal man. J Lab Clin Med 1954;44:320-332.
26. Woods JW, Blythe WB: Management of malignant hypertension complicated by renal insufficiency. N Engl J Med 1967;277:57-61.
27. Reams GP: Renal effects of antihypertensive drugs. In: Bennett WM, McCarron DA, Stein JH, Eds. Contemporary Issues in Nephrology: 28. Pharmacology and Management of Hypertension. New York: Churchill Livingstone; 1994:29-53.
28. Shannon JA, Jolliffe N, Smith HW: The excretion of urine in the dog: IV. The effect of maintenance diet, feeding, etc, upon the quantity of glomerular filtrate. Am J Physiol 1932;101:625-638.
29. Pitts RF: The effects of infusing glycine and varying the dietary protein intake on renal hemodynamics in the dog. Am J Physiol 1944;142:355-377.
30. King AJ, Levey AS: Dietary protein and renal function. J Am Soc Nephrol 1993;3:1723-1737.
31. Shipley RI, Study RS: Changes in renal blood flow, extraction of inulin, glomerular filtration rate, tissue pressure and urine flow with acute alterations in renal artery blood pressure. Am J Physiol 1951;167:676-688.
32. van Brummelen P, Woerlee M, Schalekamp MADH: Long-term versus short-term effects of hydorcholorothiazide on renal hemodynamics in essential hypertension. Clin Sci 1979;56:463-469.
33. Bauer JH, Reams GP. Beta-adrenergic antagonists and the kidney. In: Bennett WM, McCarron DA, Brenner BM, Stein JH, Eds. Contemporary Issues in Nephrology: 17. Pharmacotherapy of Renal Disease and Hypertension. New York: Churchill Livingtone; 1987:223-254.
34. Anderson S. Converting enzyme inhibitors. In: Bennett WM, McCarron DA, Brenner BM, Stein JH, Eds. Contemporary Issues in Nephrology: 17. Pharmacotherapy of Renal Disease and Hypertension. New York: Churchill Livingtone; 1987:277-297.
35. Murphy BF, Whitworth JA, Kincaid-Smith P: Renal insufficiency with combinations of angiotensin converting enzyme inhibitors and diuretics. Br Med J 1984;288: 844-845.
36. Davidson RC, Bursten SL. Calcium channel blockers in hypertension. In: Bennett WM, McCarron DA, Brenner BM, Stein JH, Eds. Contemporary Issues in Nephrology: 17. Pharmacotherapy of Renal Disease and Hypertension. New York: Churchill Livingtone; 1987:299-322.
37. Modification of Diet in Renal Disease Study Group (prepared by Levey AS, Bosch JP, Coggins CH, Greene T, Mitch WE, Schluchter MD): Effects of diet and blood pressure on creatinine clearance and serum creatinine concentration in the MDRD Study. J Am Soc Nephrol 1996;7:556-565.
38. Bjorck S, Mulec H, Johnsen SA, Norden G, Aurell M: Renal protective effect of enalapril in diabetic nephropathy. Br Med J 1992;304:339-343.
39. Lebovitz HE, Wiegmann TB, Cnaan A, et al.: Renal protective effects of enalapril in hypertensive NIDDM: Role of baseline albuminuria. Kidney Int 1994;45[Suppl 45]:S150-S155.
40. Parving HH, Hommel E, Smidt UM: Protection of kidney function and decrease in albuminuria by captopril in insulin-dependent diabetics with nephropathy. Br Med J 1988;297:1086-1091.
41. Romero R, Salinas I, Lucas A, Tebddo J, Audi L, Sanmarti A: Comparative effects of captopril versus nifedipine on proteinuria and renal function of type II diabetic patients. Diabetes Res Clin Pract 1992;17:191-198.
42. Romero R, Salinas I, Lucas A, et al.: Renal function changes in microalbuminuric normotensive type II diabetic patients treated with angiotensin-converting enzyme inhibitors. Diabetes Care 1993;16:597-600.
43. Lacourciere Y, Nadeau A, Poirier L, Tancrede G: Captopril or conventional therapy in hypertensive type II diabetics: Three-year analysis. Hypertension (Dallas) 1993; 21:786-794.
44. Bauer JH, Reams GP, Hewett J, Klachko D: A randomized, double-blind, placebo-controlled trial to evaluate the effect of enalapril in patients with clinical diabetic nephropathy. Am J Kidney Dis 1992;20:443-457.
45. Slataper R, Vicknair N, Sadler R, Bakris GL: Comparative effects of different antihypertensive treatments on progression of diabetic renal disease. Arch Intern Med 1993;153:973-980.
46. Bakris GL, Barnhill BW, Sadler R: Treatment of arterial hypertension in diabetic man: Importance of therapeutic selection. Kidney Int 1992;41:912-919.
47. Hansen HP, Rossing P, Tarnow L, Jielsen PS, Jensen B, Parving HH: Elevated GFR after withdrawal of chronic antihypertensive treatment in diabetic nephropathy (Abstract). J Am Soc Nephrol 1994;5:378A.
48. Apperloo AJ, de Zeeuw D, van Essen G, de Jong PE: The initial GFR decline on antihypertensive treatment in long-term intervention trials is reversible after withdrawal of treatment [Abstract]. J Am Soc Nephrol 1994; 5:324A.
49. Modification of Diet in Renal Disease Study Group (prepared by Levey AS, Beck GJ, Caggiula AW, Greene T, Kusek JW, Striker GE, Klahr S): Trends toward a beneficial effect of a low protein diet during additional follow-up in the Modification of Diet in Renal Disease Study [Abstract]. J Am Soc Nephrol 1994;5:336A.
50. Mogensen CE, European Microalbuminura Captopril Study Group: Effect of captopril on progression to overt clinical proteinuria in patients with renal disease in insulin-dependent diabetes mellitus. JAMA 1994;271: 275-279.